Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurch...(. BinationalIndustrial Research and Deve...)

Collaborations and Licensing

- Johns Hopkins University School of Medicine has initiated a clinical assessment study to compare Rosetta Genomics' miRview(TM) squamous, which differentiates squamous from non squamous non small cell lung cancer, with available immunohistochemistry methods.

- Initiated a collaboration with the National Institute of Health (NIH) to identify microRNAs involved in the progression of the Human Immunodeficiency Virus (HIV), that may be used as potential drug targets.

Publications

- Published results of a study conducted by Rosetta Genomics' scientists describing the identification of microRNA biomarkers in blood serum. The findings, published online in the peer-reviewed journal PLOS One, demonstrate that microRNAs have the potential to be used as clinical biomarkers for a wide range of indications in cancer and women's health.

- A collaborative study published online in Biochemical and Biophysical Research Communications, by scientists from the Weizmann Institute of Science and scientists at Sheba Medical Center, with the aid of Rosetta Genomics, has demonstrated that a microRNA first disclosed by the company increased the efficacy of Imatinib (Gleevec(R)) in Glioblastoma (GBM), the most common and most aggressive type of primary brain tumor.

    Conferences and Events

    Rosetta Genomics presented at the following conferences and
    events:

    - Maxim Group Growth Conference, New York City, October, 2008.

    - EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in
      Cancer". October 2008, Florida.

    - Oppenheimer 19th Annual Healthcare Conference. November
      2008, New York City.

    - AACR's centennial conference "Translational Cancer Medicine
      2008: Bridging the Lab and Clinic in Cancer Medicine" Molecular
     
'/>"/>
SOURCE  Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 
Related biology technology :

1. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
2. /C O R R E C T I O N -- Rosetta Genomics Ltd/
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
5. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
6. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
7. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Rosetta Genomics Reports Second Quarter 2008 Financial Results
10. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
11. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.